Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3335
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03827629 | A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers | ||
| NCT03778931 | Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer | ||
| NCT04783181 | A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) | ||
| NCT02536495 | Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer | ||
| NCT00277875 | STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH | ||
| NCT01067807 | Proellex Pharmacokinetics Bridging Study | ||
| NCT04535531 | A Phase 3 Molluscum Contagiosum Efficacy and Safety Study | ||
| NCT03144245 | Study of AMV564 in Patients With AML | ||
| NCT03278028 | A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts | ||
| NCT01620801 | Hemophilia B Gene Therapy With AAV8 Vector | ||
| NCT04798430 | Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction | ||
| NCT03101267 | A Dose-finding Study of ASP4070 | ||
| NCT03193463 | Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy | ||
| NCT04052711 | A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design | ||
| NCT02895100 | Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis | ||
| NCT05416307 | Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) | ||
| NCT04256707 | Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment | ||
| NCT00429936 | Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration | ||
| NCT02300233 | The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia | ||
| NCT03236064 | Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury | ||
| NCT02210325 | Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea | ||
| NCT04397900 | Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes | ||
| NCT04113616 | An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) | ||
| NCT03736447 | Peanut Oral Immunotherapy Study of Early Intervention for Desensitization | ||
| NCT05298332 | Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects | ||
| NCT04268784 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy Volunteers | ||
| NCT05838833 | Ointment to Prevent Scar After Thyroidectomy | ||
| NCT05612633 | A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN | ||
| NCT03988335 | A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) | ||
| NCT00292084 | An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection | ||
| NCT04573478 | Atrasentan in Patients With IgA Nephropathy | ||
| NCT03837743 | Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis | ||
| NCT03680521 | Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma | ||
| NCT02664935 | National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer | ||
| NCT00635089 | Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis | ||
| NCT07402876 | A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma | ||
| NCT05028764 | Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers | ||
| NCT02431364 | Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults | ||
| NCT01540409 | Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy | ||
| NCT06128564 | A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) | ||
| NCT06181136 | Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) | ||
| NCT03051100 | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C | ||
| NCT07161011 | Phase 2b Controlled Study of Dosing Techniques - Part B | ||
| NCT05712707 | Sublingual Dexmedetomidine for Treating Opioid Withdrawal | ||
| NCT07211633 | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS) | ||
| NCT01776606 | Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | ||
| NCT03909152 | A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone | ||
| NCT00958334 | Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 | ||
| NCT05919563 | LTFU Study of Subjects Who Received GRNOPC1 | ||
| NCT05121038 | CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab |
